1d
KHQA on MSNBlessing Health introduces new FDA-approved nasal spray treatment for resistant depressionUp to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...
Johnson & Johnson will stop late-stage studies of its experimental drug to treat major depressive disorder due to a lack of ...
The oxytocin system - which helps release breast milk and strengthens the bond between mother and baby - may be affected ...
The oxytocin system—which helps release breast milk and strengthens the bond between mother and baby—may be affected during ...
In a new study on mice, an experimental antibody treatment reduced the lingering after-effects of head injuries.
Analysts do not believe the Phase III stumble for aticaprant will derail J&J’s broader neuroscience strategy, particularly ...
The eight-week, quadruple-masked, dose-finding, core stage of the Phase 2b clinical trial is evaluating the efficacy and ...
A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.
The FDA has approved Neffy, a needle-free nasal spray, for children aged 4 and up, providing fast and effective treatment for severe allergic reactions and anaphylaxis.
The Daily Gate mobile app brings you the latest local breaking news, updates, and more. Read the Daily Gate on your mobile device just as it appears in print.
Nasal Spray 10mg, is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results